June 19, 2017 / 11:37 AM / 2 months ago

BRIEF-Intellia Therapeutics announces patent for CRISPR/CAS genome editing in China

June 19 (Reuters) - Intellia Therapeutics Inc:

* Intellia Therapeutics announces patent for CRISPR/CAS genome editing in China

* Intellia Therapeutics Inc - patent includes claims covering methods for editing DNA in non-cellular and cellular settings

* Intellia Therapeutics - patent also includes CRISPR/CAS9 composition of matter and system claims for use in any setting

* Intellia Therapeutics Inc - SIPO has indicated it will grant a patent broadly covering CRISPR/CAS9 single-guide gene editing methods and compositions Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below